Abstract Normal fusion of developing eyelids requires coordination of inductive signals from the eyelid mesenchyme with migration of the periderm cell layer and constriction of the eyelids across the eye. Failure of this process results in an eyelids open at birth (EOB) phenotype in mice. We have identified a novel spontaneous allele of Alx4 that displays EOB, in addition to polydactyly and cranial malformations. Alx4 is expressed in the eyelid mesenchyme prior to and during eyelid fusion in a domain overlapping the expression of genes that also play a role in normal eyelid development. We show that Alx4 mutant mice have reduced expression of Fgf10, a key factor expressed in the mesenchyme that is required for initiation of eyelid fusion by the periderm. This is accompanied by a reduced number of periderm cells expressing phosphorylated c-Jun, consistent with the incomplete ablation of Fgf10 expression. Together, these data demonstrate that eyelid fusion in mice requires the expression of Alx4, accompanied by the loss of normal expression of essential components of the eyelid fusion pathway.
Introduction
During development, the mouse eyelids close and fuse temporarily, reopening at approximately postnatal day 14. Similarly, human eyelids fuse at approximately week 9 of gestation, reopening prior to birth at around the 6 months time point. It is thought this event is important for the normal development of the eyelid margin, and failures of this process can result in a variety of eye defects in humans and mice (Zieske 2004; Byun et al. 2011) . Fusion of the eyelid is initiated, in part, by inductive signals from the eyelid mesenchyme that stimulate proliferation and migration of the periderm cell layer of the epithelium at approximately embryonic day 14.5 (E14.5). The periderm expands and migrates across the surface of the cornea, completing fusion by *E15.5-E16. The basal epithelial layer and mesenchymal core of each eyelid follow the periderm migration, arriving at the center of the eye in close proximity, but remaining completely separate. Failure of this process results in an EOB phenotype in neonatal mice. Because eyelid closure appears to be important for development of the cornea during gestation (Zieske 2004) , this frequently leads to corneal opacity and other defects in surviving adult mice (Toonen et al. 2012 , for example) and more recently has been implicated in the normal development of the meibomian gland, tarsal muscles and other muscles of the eye (Meng et al. 2014) . Induction and migration of the eyelid epithelium is thought to involve many of the same genes activated during wound healing in the adult (Grose 2003; Li et al. 2003; Martin and Parkhurst 2004; Xia and Kao 2004) , and thus represents a useful model for understanding regulation of wound healing pathways.
A number of signaling molecules and pathways regulate eyelid fusion, as revealed by mouse mutations that result in an EOB phenotype (Xia and Kao 2004) . These include growth factors and receptors such as Fgf10 (Tao et al. 2005) , Fgfr2 (Li et al. 2001) , Inhbb (Schrewe et al. 1994; Vassalli et al. 1994) , Tgfa (Luetteke et al. 1993; Mann et al. 1993) , and Egfr (Threadgill et al. 1995) , and downstream effector genes such as Osr2 (Gao et al. 2009 ), Jun (c-Jun) (Li et al. 2003; Zenz et al. 2003) , Map3k1 (MEKK) (Zhang et al. 2003) , and Rock1 . This body of work supports a model where inductive signals expressed in the eyelid mesenchyme, such as Fgf10, activate signaling pathways in the adjacent epithelium at the distal tip of the developing lid (Tao et al. 2005 ). This in turn stimulates the periderm cell layer to proliferate and migrate across the surface of the cornea, which is followed by the progressive constriction of the eyelids themselves about the closure axis. Interestingly, recent work suggests this migration of the periderm cells is not strictly required for fusion; rather intercalation of the underlying epithelium drives closure (Heller et al. 2014) . While much is known about the molecular signals that govern the later portion of this process, the early events that regulate inductive signals from the mesenchyme are poorly understood.
Alx4 is a member of the aristaless-like homeobox domain gene family, comprising transcription factors defined by a paired-type homeobox domain and a conserved C-terminal ''aristaless'' domain. The mesenchyme of the developing craniofacial structures and limb buds display prominent expression of Alx4 and several family members, including Cart1 (Qu et al. 1997; Beverdam et al. 2001) , which physically interacts with Alx4 and is required for transcriptional activation. Targeted null mutations of Alx4 result in highly penetrant preaxial polydactyly, skull abnormalities resulting from defects in parietal bone formation and ventral body wall fusion defects (Qu et al. 1997 ). The spontaneous mutant Strong's luxoid (lst) (Forsthoefel 1963 ) is caused by a deletion in the Alx4 gene, and displays a subset of the knockout phenotypes, indicating the range and penetrance of phenotypes are affected by genetic background (Qu et al. 1998) . While the role of Alx4 in limb and skull development is well studied (Qu et al. 1997; Antonopoulou et al. 2004; Kuijper et al. 2005) , no analysis of the eyelid fusion defect has been performed.
In this study, we explore the mechanisms that govern embryonic eyelid fusion, using a novel spontaneous mutant allele of Alx4. Mice harboring this mutation are born with an EOB phenotype. We find that ALX4 protein is expressed in the mesenchyme directly adjacent to the palpebral conjunctival epithelium, overlapping the expression domain of known mediators of eyelid fusion, including Fgf10. We show a clear downregulation of Fgf10 expression in the developing eyelids of Alx4 mutants indicating that Alx4 plays a critical role in stimulating Fgf10 expression during eyelid fusion.
Results
As part of a longstanding program to identify, characterize, and positionally clone mouse mutants with craniofacial malformations, we identified Nm3768, a semi-dominant spontaneous mutation characterized by a short nose and frequent preaxial polydactyly on one hind limb.
Intercrosses of affected animals yielded litters with frequent perinatal lethality, but a few individual putatively homozygous adult survivors were noted. These mice display cataracts, short nose and wide-set eyes, dorsal alopecia, polydactyly on all four limbs, and distinct abnormalities in the frontal bones of the skull (Fig. 1a, b) . Further inspection of newborns from intercrosses revealed a consistent phenotype at birth, including EOB, preaxial polydactyly on all four limbs, and large bulges at the anterior portion of the head, indicating defective formation of the calvaria (Fig. 1c) . Together, these data suggest mice with the short nose and single limb polydactyly are heterozygous for the Nm3768 mutation, while those that exhibit the EOB phenotype are homozygous for the mutation.
We mapped the causative gene of Nm3768 using the dominant phenotypes of a short nose and polydactyly. Nm3768 was found to reside on chromosome 2 (Mmu2) between markers D2Mit15 at 92 Mb and D2Mit386 at 94 Mb (genome build GRCm38/mm10). Several alleles of one candidate gene, Alx4, appeared to harbor a number of similar phenotypes in the homozygous state including preaxial polydactyly, dorsal alopecia, EOB, and craniofacial abnormalities (Qu et al. 1997; Qu et al. 1998) .
To test whether Nm3768 displayed any alterations in the Alx4 gene, we PCR amplified and sequenced fragments of the four exons from homozygous mutant samples. Although we identified no coding mutations, we were unable to amplify fragments from the 5 0 portion of exon 1, including both the transcriptional and translational start sequences. This suggested that a deletion, encompassing part of the first exon of Alx4, is the cause of the Nm3768 phenotype. We also failed to generate additional amplicons up to 30 Kb 5 0 of the first exon of Alx4, suggesting the presence of a large 30-35 kb deletion that includes the transcription and translation start site. Southern Blot analysis using both an internal an external probe ( Fig. 2a) clearly shows a band shift in mutants consistent with a 33.4 Kb deletion (Fig. 2d) . Based on these results, we were able to design primers spanning the breakpoint, confirmed the precise deletion coordinates of Mmu2:93, 612, 646, 101 (Fig. 2b) , and designed a genotyping assay to unambiguously distinguish all three genotype classes (Fig. 2c) .
To confirm Alx4 is the causative gene for Nm3768, we tested allelism using Strong's Luxoid Jackson(B6C3Fe a/aAlx4 lst-J /J; STOCK #000221), a spontaneous allele of Alx4 (Qu et al. 1998 ). The Alx4 lst-J /J allele failed to complement the EOB and polydactyly phenotype of Nm3768 in compound double heterozygous mutants (data not shown), unambiguously establishing Nm3768 as a new allele of Alx4 (Alx4 lst-2J /J). To confirm that ALX4 protein expression was altered in Alx4 lst-2J /J mice, we performed immunostaining on coronal sections of E14.5 embryo heads. Homozygotes show a clear lack of specific nuclear staining in mesenchymal cells along the medial aspect of the developing eyelid compared to littermate controls ( Fig. 3a, b ). These results suggest Alx4 lst-2J /J is a null allele of the Alx4 gene, resulting in loss of protein expression. In addition, Hematoxylin and Eosin (H&E) staining of E14.5 eyelids (Fig. 3c, d ) suggests the initial formation and outgrowth of the eyelid core are unaffected in mutants as the size and shape appear identical to controls at this stage and at E15.5 (data not shown). Accordingly, no differences in proliferation or apoptosis in mutant eyelids were observed (data not shown).
Prior description of the Alx4 knockout phenotype noted open eyelids at birth, but no further phenotypic or mechanistic characterization was performed. Given the mesenchymal expression of the ALX4 protein, we reasoned that Alx4 must regulate the activation of the eyelid tip periderm in a cell nonautonomous fashion through signaling intermediates expressed in the adjacent mesenchymal compartment. A number of genes are expressed in a domain overlapping Alx4, including Osr2, and Fgf10. Null mutations in Osr2 and Fgf10 lead to the EOB phenotype (Tao et al. 2005; Gao et al. 2009 ), and Fgf10 has been shown to directly regulate activation of the eyelid tip periderm through engagement of the Fgfr2 receptor (Tao et al. 2005) . In Alx4 lst-2J /J mutants, there is a consistent reduction in Fgf10 staining in the eyelid mesenchyme, overlapping the Alx4 expression domain, while no differences in expression of Osr2 or Fgfr2 are noted (Fig. 4) . This would support a model where Alx4 regulates eyelid closure through the activity of Fgf10.
Because Fgf10 is only weakly expressed, we confirmed our preliminary finding by quantitative RT-PCR (qPCR) on E14.5 whole eyelids. As shown in Fig. 5 , Fgf10 expression is significantly lower in Alx4 mutants, and there is an apparent, though not statistically significant, decrease in Alx4 heterozygotes, suggesting the relative dose of ALX4 protein is important in regulating Fgf10. Consistent with our in situ hybridization findings, Fgfr2 expression is unaffected, while Alx4 expression decreases with gene copy number, as expected. We did not observe any significant difference in the expression of putative downstream effectors of Fgf10 function, including Bmp4 (Huang et al. 2009 ), Ihnbb (Tao et al. 2005) , and Shh (Tao et al. 2005) (Fig. 5) . However, these genes are normally expressed in fairly limited domains, and therefore, our assay might lack the sensitivity to detect small changes. This is also consistent with the moderate, but incomplete, loss of Fgf10 expression. No differences were noted in any targets (apart from Alx4) at E15.5 (data not shown), consistent with the model that Alx4 regulates the initiation of periderm outgrowth via Fgf10 expression in the mesoderm at E14.5.
To investigate the functional impact of the Alx4 mutation on the periderm, additional markers of periderm structure (KRT6) (Mazzalupo and Coulombe 2001; Shimizu et al. 2005 ) and activation (phospho-c-Jun) were examined (Li et al. 2003; Zenz et al. 2003) . As shown in Fig. 6 , KRT6 expression is detected in the periderm of both control and homozygous mutant samples, although the extent of staining is reduced in mutants reflecting the reduced number of total periderm cells. These data lead us to conclude that the periderm in Alx4 mutants forms properly, but fails to respond to the signals to expand and migrate across the cornea. Similarly, we see evidence of activation of the JNK signaling pathway, a known mediator of periderm cell migration, in both mutants and controls. However, as with KRT6, a reduced number of cells display activation of JNK as measured by phospho-c-Jun staining. These data suggest an overall reduction, but not complete ablation, of normal periderm activation during eyelid fusion in Alx4 mutants. This is consistent with a reduced, but not absent, level of Fgf10 expression and suggests a minimum threshold of periderm activation by Fgf10 is required for the migration and fusion of the eyelids.
Discussion
In this study, we present a detailed analysis of the EOB phenotype of a novel allele of Alx4. While our new allele Alx4 lst-2J recapitulates many of the features of the original Strong's Luxoid and subsequent targeted mutations, including preaxial polydactyly and, dorsal alopecia, defects in calvaria development and EOB (Qu et al. 1997; Qu et al. 1998; Qu et al. 1999; Antonopoulou et al. 2004 ), we did not observe any instances of omphalocele in severely affected mice. This could be attributed to lower penetrance in our model due to an accumulation of modifiers, which has been maintained as a closed colony for several generations. We have not examined neonates in sufficient numbers to rule out rare instances of omphalocele, which along with severe calvarial defects would explain the small number of viable adult homozygotes. We demonstrate that our allele is a clear null, like the targeted mutation, so our observation is unlikely to be due to a hypomorphic effect of the mutation. lst-2J deletion (b), which was confirmed by sequencing. Allele-specific genotyping c confirms that severely affected mutant mice are homozygous for the deletion. Notably, some unaffected controls were shown to be heterozygous for the deletion, indicating the dominantly inherited short nose, single limb polydactyly phenotype is incompletely penetrant. Southern blot analysis d confirms the genomic structure of the deletion. The expected 3.8 Kb WT band from probe A is converted to a 8.4 Kb band in homozygous mutant animals, consistent with the predicted band size of the deletion, while no signal is detected in mutant mice for internal probe B Prior work examining the function Alx4 in vivo is focused on its role in the developing limb and skull (Qu et al. 1997; Qu et al. 1998; Qu et al. 1999; Antonopoulou et al. 2004 ). In the case of the former, Alx4 is thought to provide anterior identity to the developing limb bud, repressing the expression of posterior-specific genes. Of interest, Alx4 -/-mutants display ectopic expression of Fgf4 in the anterior limb bud (Qu et al. 1997) , suggesting Alx4 functions directly or indirectly to downregulate the Fgf4 gene. We observe the opposite effect on Fgf10 in the eyelid mesenchyme, where loss of Alx4 leads to a reduction on Fgf10 levels. This is consistent with other work that demonstrates Alx4 can function as a transcriptional activator (Qu et al. 1999) . Interestingly, mice homozygous for a null mutation in Fgf10 lack limbs entirely.
Eyelid fusion in mice requires both autocrine signals within the periderm cell population at the eyelid tip and paracrine instructive signals from the adjacent mesenchyme. A complex array of signaling components and pathways has been implicated in this process, including Activin-beta-B (Innhb)/ JNK/c-JUN, Tgfa/HB-EGF/ERK, and BMP4/Smad. A consensus model has emerged in which expression of Fgf10 in the mesenchyme of the developing eyelid triggers activation of these pathways in the adjacent epithelium and periderm to initiate cell migration and ultimately eyelid fusion. While Fgf10 mice display an EOB phenotype (Sekine et al. 1999; Tao et al. 2005) , it is distinct from that of the knockout of its receptor Fgfr2 (Li et al. 2001) , in which the core of the eyelids fails to form well prior to the initiation of fusion, suggesting additional roles for Fgfr2 earlier in eyelid development. Our ability to detect phospho-c-Jun in a smaller number of periderm cells is consistent with the partial, but incomplete downregulation of Fgf10, and suggests there is a threshold of activation required for proper morphogenesis to proceed. The regulation of Fgf10 expression itself, however, is not understood. Alx4 is a transcription factor that binds, both independently and in a cooperative fashion with Cart1 (Qu et al. 1999) , to a paired-type homeodomain consensus sequence of 5 0 -TAAT NNN ATTA-3 0 . Interestingly, two perfect consensus motifs lie *2.5 Kb 5 0 of the first exon of Fgf10, although we have not explored the potential for a direct effect of Alx4 on the transcriptional activity of the Fgf10 promoter. Consistent with this, our work in this study strongly suggests that Alx4 functions upstream of Fgf10 and is necessary for proper expression of this key regulator of eyelid fusion.
Experimental procedures

Mice
Alx4
lst-2J /J mice were identified as part of the Jackson Laboratory Craniofacial Mutant Resource program. The spontaneous mutation arose on a C57BL/6 J background. A colony was established and maintained by brother/sister mating of affected heterozygote by unaffected littermate. B6C3Fe a/a-Alx4 lst-J /J (STOCK #000221) mice were cryorecovered from the Jackson Laboratory Repository. Mice had access to bottled acidified water (pH 2.8-3.1) and NIH 31 M feed pellets with 6 % fat (Purina Mills Inc., Richmond, IN) ad libitum. The light:dark cycle was maintained at 12:12. For timed matings, two females were placed with single housed males after 4 PM, and day 0 of pregnancy was defined as the mid point of the dark cycle prior to the appearance of a copulation plug. All procedures were approved by The Jackson Laboratory's Institutional Animal Care and Use Committee and performed in accordance with National Institutes of Health guidelines for the care and use of animals in research.
Genetic mapping
Adult dominant carriers of the Alx4 lst2J mutation were mapped with a linkage cross to A/J via a backcross strategy. Analysis of recombinants using a genome-wide panel of polymorphic microsatellite markers established linkage to Chr 2 with a minimum interval between D2Mit15 (92035835-92035976) and D2Mit386 (94018729-940188500) Mb. 5 Quantitative expression of markers of eyelid development in isolated embryonic eyelids. Expression levels of Alx4, Bmp4, Fgf10, Inhbb, and Shh measured by qPCR using Taqman probes (Applied Biosystems) on mRNA from microdissected E14.5 eyelids. For each gene, one WT sample is arbitrarily set to 1 and relative fold change calculated for the remaining samples. Asterisk indicates a significant difference (p \ 0.05) for WT versus homozygous for Fgf10 expression, determined by student's t test. Sample sizes WT = 8; Het = 9; Hom = 9 Genotyping and southern blot PCR amplicons from each exon were purified and sequenced to identify causative mutations. Primer pairs for exon one failed to generate bands in homozygotes, suggesting a 5 0 deletion. Additional small amplicons were produced at various intervals 5 0 and 3 0 of exon 1 until amplification was noted in homozygous samples. We were then able to identify two primers, Alx4 F (5 0 -TTGACTCCCAA GGGACATTC-3 0 ) and Mut R (5 0 -TCTCAGAGGTCCCTG GATTG-3 0 ), that spanned the deletion breakpoint. A third primer (WT R: 5 0 -TAGGCCCATCCAGTGACTTC-3 0 ) was designed within the deleted region to provide a genotyping assay. A 32P-labeled 591 bp probe 5 0 of the breakpoint (2:93612053-93612643) and 842 bp probe 3 0 of the breakpoint (2:93615034-93615875) were hybridized to HindIII digested genomic DNA of WT, heterozygous and mutant embryos as described.
Histology and immunostaining
To generate homozygous embryos, affected carriers or genotype-confirmed carriers were intercrossed via timed mating, setting the midpoint of the dark cycle prior to the appearance of a copulation plug as day 0 of gestation. Embryos were dissected at the times indicated and fixed in 4 % Paraformaldehyde overnight at 4°C. For histology and immunohistochemistry, embryos were washed in PBS, dehydrated through an ethanol series, and embedded in paraffin. 5-micron coronal sections through the eye were affixed to Superfrost ? slides (Fisher), dewaxed, and hydrated prior to staining with Hematoxylin and Eosin (H&E) or immunohistochemistry. Antibody staining was performed essentially as described (Murray and Gridley 2006) , using antibodies to ALX4 (Santa Cruz), KRT6 (Covance), and Phospho-c-Jun (Cell Signaling Technology) at a 1:100 dilution each. An HRP-conjugated secondary antibody (Invitrogen) was used for ALX4, and staining was visualized by DAB development (Sigma). For KRT6 and phospho-c-Jun, AlexaFluor488-conjugated (Invitrogen) secondary antibodies were used, and images captured by confocal microscopy.
In situ hybridization
Heads of embryos isolated and fixed as described above were equilibrated in a 30 % sucrose gradient overnight at 4°C and then frozen in OCT on dry ice. Twenty-micron frozen sections through the eye were affixed to Superfrost ? slides and air dried briefly prior to processing. Sections were then fixed, permeabilized with proteinase K, postfixed, dehydrated, and then hybridized overnight at 70°C using a 50 % formamide hybridization solution and 200-500 lg/microliters of digoxigenin-labeled antisense RNA probe. Following a series of SSC washes, the slides were blocked in embryo powder/sheep serum, and then incubated overnight at 4°C with an alkaline phosphataseconjugated anti-digoxygenin antibody (Roche). After washing, the slides were developed using BM purple (Roche) substrate, mounted, and imaged. Fgf10 and Fgfr2 cDNA clones were obtained from the Mammalian Gene Collection (http://mgc.nci.nih.gov/), and Osr2 was a gift from Dr. Rulang Jaing.
Quantitative PCR analysis
Individual eyelids from embryos were isolated by microdissection, stored in RNAlater (Ambion, Austin, TX) per manufacturer's instructions, and homogenized in RLT Buffer from an RNeasy Micro Kit (Qiagen, Valencia, Ca.). Total RNA was isolated according to manufacturer's protocols (Qiagen) including the optional DNase treatment step, and quality was assessed using a 2100 Bioanalyzer instrument and RNA 6000 Pico LabChip assay. 500 lg of total RNA was then reverse transcribed with random decamers and M-MLV RT using the Message Sensor RT Kit (Ambion, Austin, TX).
A portion of the cDNA was then used in a PCR reaction containing Taqman Universal PCR Master Mix (Applied Biosystems, Carlsbad, Ca) which includes AmpliTaq Gold DNA Polymerase, AmpErase UNG, dNTPs with dUTP, Passive Reference 1, and other buffer components. The gene-specific primers and probe sets were obtained from Applied Biosystem Assay on Demand service and used according to manufacturer's protocols. Real-Time PCR was performed in an AB PRISM Ò 7900HT Sequence Detection System (Applied Biosystems) with the standard protocol of 50°C for 2 min, 95°C 10 min, 40 cycles of 95°C for 15 s, and 60°for 1 min. The threshold cycle (Ct) and relative quantitation (RQ) were determined using the Sequence Detection System software (SDS2.2). For each gene, one WT sample was arbitrarily set to 1, and all other samples are calculated as relative fold change.
